Cristóbal, I.; Rubio, J.; Santos, A.; Torrejón, B.; Caramés, C.; Imedio, L.; Mariblanca, S.; Luque, M.; Sanz-Alvarez, M.; Zazo, S.;
et al. MicroRNA-199b Downregulation Confers Resistance to 5-Fluorouracil Treatment and Predicts Poor Outcome and Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer Patients. Cancers 2020, 12, 1655.
https://doi.org/10.3390/cancers12061655
AMA Style
Cristóbal I, Rubio J, Santos A, Torrejón B, Caramés C, Imedio L, Mariblanca S, Luque M, Sanz-Alvarez M, Zazo S,
et al. MicroRNA-199b Downregulation Confers Resistance to 5-Fluorouracil Treatment and Predicts Poor Outcome and Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer Patients. Cancers. 2020; 12(6):1655.
https://doi.org/10.3390/cancers12061655
Chicago/Turabian Style
Cristóbal, Ion, Jaime Rubio, Andrea Santos, Blanca Torrejón, Cristina Caramés, Laura Imedio, Sofía Mariblanca, Melani Luque, Marta Sanz-Alvarez, Sandra Zazo,
and et al. 2020. "MicroRNA-199b Downregulation Confers Resistance to 5-Fluorouracil Treatment and Predicts Poor Outcome and Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer Patients" Cancers 12, no. 6: 1655.
https://doi.org/10.3390/cancers12061655
APA Style
Cristóbal, I., Rubio, J., Santos, A., Torrejón, B., Caramés, C., Imedio, L., Mariblanca, S., Luque, M., Sanz-Alvarez, M., Zazo, S., Madoz-Gúrpide, J., Rojo, F., & García-Foncillas, J.
(2020). MicroRNA-199b Downregulation Confers Resistance to 5-Fluorouracil Treatment and Predicts Poor Outcome and Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer Patients. Cancers, 12(6), 1655.
https://doi.org/10.3390/cancers12061655